 | • レポートコード：GIR-2104Z10131 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、OAB治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。OAB治療の種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・OAB治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Astellas Pharma、Allergan、Pfizer、Teva (Activas)、Johnson & Johnson ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：抗コリン作用薬、ミラベグロン、ボトックス ・用途別分析2016年-2026年：特発性過活動膀胱、神経性過活動膀胱 ・OAB治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・OAB治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・OAB治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・OAB治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・OAB治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The OAB Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global OAB Treatment size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global OAB Treatment market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
OAB Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Anticholinergics
Mirabegron
Botox
Market segment by Application, can be divided into
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder
Market segment by players, this report covers
Astellas Pharma
Allergan
Pfizer
Teva (Activas)
Johnson & Johnson
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of OAB Treatment
1.2 Classification of OAB Treatment by Type
1.2.1 Overview: Global OAB Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global OAB Treatment Revenue Market Share by Type in 2020
1.2.3 Anticholinergics
1.2.4 Mirabegron
1.2.5 Botox
1.3 Global OAB Treatment Market by Application
1.3.1 Overview: Global OAB Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Idiopathic Overactive Bladder
1.3.3 Neurogenic Overactive Bladder
1.4 Global OAB Treatment Market Size & Forecast
1.5 Global OAB Treatment Market Size and Forecast by Region
1.5.1 Global OAB Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global OAB Treatment Market Size by Region, (2016-2021)
1.5.3 North America OAB Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe OAB Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific OAB Treatment Market Size and Prospect (2016-2026)
1.5.6 South America OAB Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa OAB Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 OAB Treatment Market Drivers
1.6.2 OAB Treatment Market Restraints
1.6.3 OAB Treatment Trends Analysis
2 Company Profiles
2.1 Astellas Pharma
2.1.1 Astellas Pharma Details
2.1.2 Astellas Pharma Major Business
2.1.3 Astellas Pharma OAB Treatment Product and Solutions
2.1.4 Astellas Pharma OAB Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Astellas Pharma Recent Developments and Future Plans
2.2 Allergan
2.2.1 Allergan Details
2.2.2 Allergan Major Business
2.2.3 Allergan OAB Treatment Product and Solutions
2.2.4 Allergan OAB Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Allergan Recent Developments and Future Plans
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer OAB Treatment Product and Solutions
2.3.4 Pfizer OAB Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Pfizer Recent Developments and Future Plans
2.4 Teva (Activas)
2.4.1 Teva (Activas) Details
2.4.2 Teva (Activas) Major Business
2.4.3 Teva (Activas) OAB Treatment Product and Solutions
2.4.4 Teva (Activas) OAB Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Teva (Activas) Recent Developments and Future Plans
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson OAB Treatment Product and Solutions
2.5.4 Johnson & Johnson OAB Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Johnson & Johnson Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global OAB Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 OAB Treatment Players Market Share
3.2.2 Top 10 OAB Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 OAB Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global OAB Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global OAB Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global OAB Treatment Revenue Market Share by Application (2016-2021)
5.2 OAB Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America OAB Treatment Revenue by Type (2016-2026)
6.2 North America OAB Treatment Revenue by Application (2016-2026)
6.3 North America OAB Treatment Market Size by Country
6.3.1 North America OAB Treatment Revenue by Country (2016-2026)
6.3.2 United States OAB Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada OAB Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico OAB Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe OAB Treatment Revenue by Type (2016-2026)
7.2 Europe OAB Treatment Revenue by Application (2016-2026)
7.3 Europe OAB Treatment Market Size by Country
7.3.1 Europe OAB Treatment Revenue by Country (2016-2026)
7.3.2 Germany OAB Treatment Market Size and Forecast (2016-2026)
7.3.3 France OAB Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom OAB Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia OAB Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy OAB Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific OAB Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific OAB Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific OAB Treatment Market Size by Region
8.3.1 Asia-Pacific OAB Treatment Revenue by Region (2016-2026)
8.3.2 China OAB Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan OAB Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea OAB Treatment Market Size and Forecast (2016-2026)
8.3.5 India OAB Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia OAB Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia OAB Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America OAB Treatment Revenue by Type (2016-2026)
9.2 South America OAB Treatment Revenue by Application (2016-2026)
9.3 South America OAB Treatment Market Size by Country
9.3.1 South America OAB Treatment Revenue by Country (2016-2026)
9.3.2 Brazil OAB Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina OAB Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa OAB Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa OAB Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa OAB Treatment Market Size by Country
10.3.1 Middle East & Africa OAB Treatment Revenue by Country (2016-2026)
10.3.2 Turkey OAB Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia OAB Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE OAB Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global OAB Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global OAB Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market OAB Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global OAB Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global OAB Treatment Revenue Market Share by Region (2021-2026)
Table 6. Astellas Pharma Corporate Information, Head Office, and Major Competitors
Table 7. Astellas Pharma Major Business
Table 8. Astellas Pharma OAB Treatment Product and Solutions
Table 9. Astellas Pharma OAB Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Allergan Corporate Information, Head Office, and Major Competitors
Table 11. Allergan Major Business
Table 12. Allergan OAB Treatment Product and Solutions
Table 13. Allergan OAB Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Pfizer Corporate Information, Head Office, and Major Competitors
Table 15. Pfizer Major Business
Table 16. Pfizer OAB Treatment Product and Solutions
Table 17. Pfizer OAB Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Teva (Activas) Corporate Information, Head Office, and Major Competitors
Table 19. Teva (Activas) Major Business
Table 20. Teva (Activas) OAB Treatment Product and Solutions
Table 21. Teva (Activas) OAB Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 23. Johnson & Johnson Major Business
Table 24. Johnson & Johnson OAB Treatment Product and Solutions
Table 25. Johnson & Johnson OAB Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Global OAB Treatment Revenue (USD Million) by Players (2019-2021)
Table 27. Global OAB Treatment Revenue Share by Players (2019-2021)
Table 28. Breakdown of OAB Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 29. OAB Treatment Players Head Office, Products and Services Provided
Table 30. OAB Treatment Mergers & Acquisitions in the Past Five Years
Table 31. OAB Treatment New Entrants and Expansion Plans
Table 32. Global OAB Treatment Revenue (USD Million) by Type (2016-2021)
Table 33. Global OAB Treatment Revenue Share by Type (2016-2021)
Table 34. Global OAB Treatment Revenue Forecast by Type (2021-2026)
Table 35. Global OAB Treatment Revenue by Application (2016-2021)
Table 36. Global OAB Treatment Revenue Forecast by Application (2021-2026)
Table 37. North America OAB Treatment Revenue by Type (2016-2021) & (USD Million)
Table 38. North America OAB Treatment Revenue by Type (2021-2026) & (USD Million)
Table 39. North America OAB Treatment Revenue by Application (2016-2021) & (USD Million)
Table 40. North America OAB Treatment Revenue by Application (2021-2026) & (USD Million)
Table 41. North America OAB Treatment Revenue by Country (2016-2021) & (USD Million)
Table 42. North America OAB Treatment Revenue by Country (2021-2026) & (USD Million)
Table 43. Europe OAB Treatment Revenue by Type (2016-2021) & (USD Million)
Table 44. Europe OAB Treatment Revenue by Type (2021-2026) & (USD Million)
Table 45. Europe OAB Treatment Revenue by Application (2016-2021) & (USD Million)
Table 46. Europe OAB Treatment Revenue by Application (2021-2026) & (USD Million)
Table 47. Europe OAB Treatment Revenue by Country (2016-2021) & (USD Million)
Table 48. Europe OAB Treatment Revenue by Country (2021-2026) & (USD Million)
Table 49. Asia-Pacific OAB Treatment Revenue by Type (2016-2021) & (USD Million)
Table 50. Asia-Pacific OAB Treatment Revenue by Type (2021-2026) & (USD Million)
Table 51. Asia-Pacific OAB Treatment Revenue by Application (2016-2021) & (USD Million)
Table 52. Asia-Pacific OAB Treatment Revenue by Application (2021-2026) & (USD Million)
Table 53. Asia-Pacific OAB Treatment Revenue by Region (2016-2021) & (USD Million)
Table 54. Asia-Pacific OAB Treatment Revenue by Region (2021-2026) & (USD Million)
Table 55. South America OAB Treatment Revenue by Type (2016-2021) & (USD Million)
Table 56. South America OAB Treatment Revenue by Type (2021-2026) & (USD Million)
Table 57. South America OAB Treatment Revenue by Application (2016-2021) & (USD Million)
Table 58. South America OAB Treatment Revenue by Application (2021-2026) & (USD Million)
Table 59. South America OAB Treatment Revenue by Country (2016-2021) & (USD Million)
Table 60. South America OAB Treatment Revenue by Country (2021-2026) & (USD Million)
Table 61. Middle East & Africa OAB Treatment Revenue by Type (2016-2021) & (USD Million)
Table 62. Middle East & Africa OAB Treatment Revenue by Type (2021-2026) & (USD Million)
Table 63. Middle East & Africa OAB Treatment Revenue by Application (2016-2021) & (USD Million)
Table 64. Middle East & Africa OAB Treatment Revenue by Application (2021-2026) & (USD Million)
Table 65. Middle East & Africa OAB Treatment Revenue by Country (2016-2021) & (USD Million)
Table 66. Middle East & Africa OAB Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. OAB Treatment Picture
Figure 2. Global OAB Treatment Revenue Market Share by Type in 2020
Figure 3. Anticholinergics
Figure 4. Mirabegron
Figure 5. Botox
Figure 6. OAB Treatment Revenue Market Share by Application in 2020
Figure 7. Idiopathic Overactive Bladder Picture
Figure 8. Neurogenic Overactive Bladder Picture
Figure 9. Global OAB Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global OAB Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global OAB Treatment Revenue Market Share by Region (2016-2026)
Figure 12. Global OAB Treatment Revenue Market Share by Region in 2020
Figure 13. North America OAB Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe OAB Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific OAB Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America OAB Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. OAB Treatment Market Drivers
Figure 18. OAB Treatment Market Restraints
Figure 19. OAB Treatment Market Trends
Figure 20. Astellas Pharma Recent Developments and Future Plans
Figure 21. Allergan Recent Developments and Future Plans
Figure 22. Pfizer Recent Developments and Future Plans
Figure 23. Teva (Activas) Recent Developments and Future Plans
Figure 24. Johnson & Johnson Recent Developments and Future Plans
Figure 26. Global OAB Treatment Revenue Share by Players in 2020
Figure 27. OAB Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 28. Global Top 3 Players OAB Treatment Revenue Market Share in 2020
Figure 29. Global Top 10 Players OAB Treatment Revenue Market Share in 2020
Figure 30. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 31. Global OAB Treatment Revenue Share by Type in 2020
Figure 32. Global OAB Treatment Market Share Forecast by Type (2021-2026)
Figure 33. Global OAB Treatment Revenue Share by Application in 2020
Figure 34. Global OAB Treatment Market Share Forecast by Application (2021-2026)
Figure 35. North America OAB Treatment Sales Market Share by Type (2016-2026)
Figure 36. North America OAB Treatment Sales Market Share by Application (2016-2026)
Figure 37. North America OAB Treatment Revenue Market Share by Country (2016-2026)
Figure 38. United States OAB Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 39. Canada OAB Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Mexico OAB Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Europe OAB Treatment Sales Market Share by Type (2016-2026)
Figure 42. Europe OAB Treatment Sales Market Share by Application (2016-2026)
Figure 43. Europe OAB Treatment Revenue Market Share by Country (2016-2026)
Figure 44. Germany OAB Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. France OAB Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. United Kingdom OAB Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Russia OAB Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Italy OAB Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Asia-Pacific OAB Treatment Sales Market Share by Type (2016-2026)
Figure 50. Asia-Pacific OAB Treatment Sales Market Share by Application (2016-2026)
Figure 51. Asia-Pacific OAB Treatment Revenue Market Share by Region (2016-2026)
Figure 52. China OAB Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Japan OAB Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. South Korea OAB Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. India OAB Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Southeast Asia OAB Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Australia OAB Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. South America OAB Treatment Sales Market Share by Type (2016-2026)
Figure 59. South America OAB Treatment Sales Market Share by Application (2016-2026)
Figure 60. South America OAB Treatment Revenue Market Share by Country (2016-2026)
Figure 61. Brazil OAB Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Argentina OAB Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Middle East and Africa OAB Treatment Sales Market Share by Type (2016-2026)
Figure 64. Middle East and Africa OAB Treatment Sales Market Share by Application (2016-2026)
Figure 65. Middle East and Africa OAB Treatment Revenue Market Share by Country (2016-2026)
Figure 66. Turkey OAB Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Saudi Arabia OAB Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. UAE OAB Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Methodology
Figure 70. Research Process and Data Source
世界の若年性特発性関節炎治療市場規模・現状・予測（2021年-2027年） Arthritis is a very common disease but it is not well understood yet. Arthritis is basically joint pain or joint disease. Basically Juvenile idiopathic arthritis or juvenile rheumatoid arthritis is the common inflammatory arthritis of childhood and Common symptom of Juvenile idiopathic arthritis is …- 世界の全身性特発性若年性関節炎治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Systemic Idiopathic Juvenile Arthritis Treatment Market The global Systemic Idiopathic Juvenile Arthritis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard ac…
- 世界の特発性頭蓋内圧亢進症治療市場規模・現状・予測（2021年-2027年） Idiopathic intracranial hypertension is characterized by a buildup of the cerebrospinal fluid causing increase in the blood volume in vessels surrounding the brain and increase in brain swelling. The increase in salt intake causes water retention in the body together with fat adding on to the calori…
- 世界の過活動膀胱治療薬市場規模・現状・予測（2021年-2027年） Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). North America is the largest consumption market of Overactive …
- 世界のスウェーデンポルフィリン症治療市場規模・現状・予測（2021年-2027年） Swedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias. Market Analysis and Insights: Global Swedish Porphyria Treatment Market The global Swedish P…